Christiane Jaeger

Title: The Innovative Work of Christiane Jaeger: Pioneering Antibody Separation Techniques

Introduction

Christiane Jaeger, an accomplished inventor based in Niederweningen, Switzerland, has made significant contributions to the field of immunology through her work on antibodies. With a total of three patents to her name, Jaeger's innovations focus on the analytical detection and separation of fucosylated antibodies, which are crucial for understanding their biological functions and therapeutic applications.

Latest Patents

Jaeger's most recent patents include:

1. **A-fucosylation detection in antibodies** - This invention describes a novel analytical method for determining the quantity and distribution of fucose per Fc region within an antibody preparation. This method enables researchers to analyze antibody modifications that can impact efficacy and safety.

2. **Separation method for fucosylated antibodies** - This patent relates to a method for separating antibodies based on their degrees of fucosylation. The technique employs binding affinity to Fc receptors, facilitating the isolation of antibodies with varying fucosylation profiles. This advancement is essential for optimizing antibody engineering and therapeutic applications.

Career Highlights

Throughout her career, Christiane Jaeger has collaborated with notable organizations such as Roche Glycart AG and Hoffmann-La Roche Inc. Her work has been instrumental in advancing antibody therapies and improving analytical techniques used in biopharmaceutical development.

Collaborations

Jaeger has also worked closely with esteemed colleagues in the field, including Pablo Umana and Peter Sondermann. Together, they have contributed to a deeper understanding of antibody functionality and have driven innovation in therapeutic antibody design.

Conclusion

Christiane Jaeger exemplifies the spirit of innovation in the field of immunology, with her patents showcasing her commitment to enhancing antibody technology. Her work not only pushes the boundaries of scientific research but also holds the potential to improve patient outcomes in therapeutic settings. As she continues to contribute to the field, her impact will undoubtedly influence future developments in antibody therapies.